171 related articles for article (PubMed ID: 30833174)
1. Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-α) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
Hemida MA; AbdElmoneim NA; Hewala TI; Rashad MM; Abdaallah S
Clin Breast Cancer; 2019 Jun; 19(3):e407-e414. PubMed ID: 30833174
[TBL] [Abstract][Full Text] [Related]
2. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
Yao S; Zirpoli G; Bovbjerg DH; Jandorf L; Hong CC; Zhao H; Sucheston LE; Tang L; Roberts M; Ciupak G; Davis W; Hwang H; Johnson CS; Trump DL; McCann SE; Ademuyiwa F; Pawlish KS; Bandera EV; Ambrosone CB
Breast Cancer Res; 2012 Apr; 14(2):R58. PubMed ID: 22480149
[TBL] [Abstract][Full Text] [Related]
3. Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.
Davoodi F; Brenner RV; Evans SR; Schumaker LM; Shabahang M; Nauta RJ; Buras RR
J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):147-53. PubMed ID: 7662588
[TBL] [Abstract][Full Text] [Related]
4. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the human vitamin D3 receptor promoter in breast cancer cells is mediated through Sp1 sites.
Wietzke JA; Ward EC; Schneider J; Welsh J
Mol Cell Endocrinol; 2005 Jan; 230(1-2):59-68. PubMed ID: 15664452
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue inflammation and
Castellano-Castillo D; Morcillo S; Clemente-Postigo M; Crujeiras AB; Fernandez-García JC; Torres E; Tinahones FJ; Macias-Gonzalez M
Clin Epigenetics; 2018; 10():60. PubMed ID: 29719581
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.
Thill M; Fischer D; Hoellen F; Kelling K; Dittmer C; Landt S; Salehin D; Diedrich K; Friedrich M; Becker S
Anticancer Res; 2010 May; 30(5):1673-9. PubMed ID: 20592360
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women.
de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP
J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688
[TBL] [Abstract][Full Text] [Related]
10. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
11. The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.
Peppone LJ; Rickles AS; Janelsins MC; Insalaco MR; Skinner KA
Ann Surg Oncol; 2012 Aug; 19(8):2590-9. PubMed ID: 22446898
[TBL] [Abstract][Full Text] [Related]
12. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer.
de Lyra EC; da Silva IA; Katayama ML; Brentani MM; Nonogaki S; Góes JC; Folgueira MA
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):184-92. PubMed ID: 16828283
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and adipose tissue vitamin D receptor gene expression: relationship with obesity and type 2 diabetes.
Clemente-Postigo M; Muñoz-Garach A; Serrano M; Garrido-Sánchez L; Bernal-López MR; Fernández-García D; Moreno-Santos I; Garriga N; Castellano-Castillo D; Camargo A; Fernández-Real JM; Cardona F; Tinahones FJ; Macías-González M
J Clin Endocrinol Metab; 2015 Apr; 100(4):E591-5. PubMed ID: 25706239
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease.
Handel AE; Sandve GK; Disanto G; Berlanga-Taylor AJ; Gallone G; Hanwell H; Drabløs F; Giovannoni G; Ebers GC; Ramagopalan SV
BMC Med; 2013 Jul; 11():163. PubMed ID: 23849224
[TBL] [Abstract][Full Text] [Related]
15. Single-Nucleotide Polymorphisms in Vitamin D-Related Genes May Modify Vitamin D-Breast Cancer Associations.
O'Brien KM; Sandler DP; Kinyamu HK; Taylor JA; Weinberg CR
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1761-1771. PubMed ID: 28830874
[No Abstract] [Full Text] [Related]
16. How would serum 25(OH)D level change in patients with inflammatory bowel disease depending on intestinal mucosa vitamin D receptor (VDR) and vitamin D1-α hydroxylase (CYP27B1)?
Huang J; Chen T; Liu Y; Lyu L; Li X; Yue W
Turk J Gastroenterol; 2019 Feb; 30(2):132-138. PubMed ID: 30429108
[TBL] [Abstract][Full Text] [Related]
17. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
18. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
19. Plasma 25-Hydroxyvitamin D Levels and VDR Gene Expression in Peripheral Blood Mononuclear Cells of Leukemia Patients and Healthy Subjects in Central Kazakhstan.
Zhumina AG; Li K; Konovalova AA; Li YA; Ishmuratova MY; Pogossyan GP; Danilenko M
Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357551
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene BsmI polymorphisms in Egyptian children and adolescents with systemic lupus erythematosus: A case-control study.
Azab SF; Ali YF; Farghaly MAA; Hamed ME; Allah MAN; Emam AA; Abdelsalam NI; Hashem MIA; Gawish HH; Nabil RM; Kamel LM; Fahmy DS; Alsayed SF; Al Azizi NM; Al-Akad GM; Noah MA; Abdelrahman HM; Ahmed AR; Bendary EA
Medicine (Baltimore); 2016 Nov; 95(46):e5233. PubMed ID: 27861345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
